Gilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?

Insider buying vs selling

Have Gilead Sciences Inc insiders been buying or selling?
Merdad ParseyChief Medical Officer2024-04-012,000$72.96
Johanna MercierChief Commercial Officer2024-03-104,559$75.12
Sandra PattersonSVP Controllership2024-03-10790$75.12
Merdad ParseyChief Medical Officer2024-03-104,803$75.12
Andrew D. DickinsonChief Financial Officer2024-03-104,505$75.12
Deborah H. TelmanEVP Corporate Affairs GC2024-03-10846$75.12
Daniel Patrick OdayChairman CEO2024-03-1013,782$75.12
Merdad ParseyChief Medical Officer2024-02-298,230$72.74
Merdad ParseyChief Medical Officer2024-02-282,000$73.18
Johanna MercierChief Commercial Officer2024-01-3122,509$78.26

1 of 5

GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GILD insiders and whales buy or sell their stock.

GILD Shareholders

What type of owners hold Gilead Sciences Inc stock?
Blackrock Inc9.86%122,793,011$8.36BInstitution
Vanguard Group Inc8.98%111,822,428$7.61BInstitution
Capital World Investors6.69%83,364,123$5.67BInstitution
Capital Research Global Investors4.79%59,657,126$4.06BInstitution
State Street Corp4.78%59,536,425$4.05BInstitution
Dodge Cox2.67%33,295,023$2.27BInstitution
Geode Capital Management LLC2.03%25,274,185$1.72BInstitution
Wellington Management Group LLP1.50%18,630,134$1.27BInstitution
Morgan Stanley1.43%17,801,718$1.21BInstitution
Fmr LLC1.37%17,097,648$1.16BInstitution

1 of 3

GILD vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GILD83.54%1.09%Net SellingNet Selling
BMY76.46%0.36%Net SellingNet Selling
BIIB87.86%2.11%Net SellingNet Selling

Gilead Sciences Stock Ownership FAQ

Who owns Gilead Sciences?

Gilead Sciences (NASDAQ: GILD) is owned by 83.54% institutional shareholders, 1.09% Gilead Sciences insiders, and 15.37% retail investors. Blackrock Inc is the largest individual Gilead Sciences shareholder, owning 122.79M shares representing 9.86% of the company. Blackrock Inc's Gilead Sciences shares are currently valued at $8.36B.

If you're new to stock investing, here's how to buy Gilead Sciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.